Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yanreqing is a Traditional Chinese Medicine (TCM) product in tablet form, manufactured by Jiangxi Jingtong Meilian Pharmaceutical. It belongs to the therapeutic category of 'heat-clearing and detoxifying' (Qing Re Jie Du) agents. The formulation is primarily indicated for the treatment of respiratory tract infections, including acute bronchitis, pneumonia, and upper respiratory tract infections characterized by symptoms such as high fever, sore throat, and cough. As a multi-herb TCM preparation, it typically contains ingredients such as *Scutellaria baicalensis*, *Gardenia jasminoides*, and *Lonicera japonica*, which provide synergistic anti-inflammatory, antipyretic, and antimicrobial activities. The product is approved and marketed in China for oral administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yanreqing.